Search Results
Mar 24, 2026, 10:32 ET Continuity Biosciences y Breakthrough T1D colaboran para impulsar la plataforma de terapia celular NICHE®
también por la eficacia con la que se puedan administrar, proteger y mantener dichas terapias a lo largo del tiempo", afirmó Ramakrishna Venugopalan, PhD, MBA, cofundador y consejero delegado de Continuity Biosciences. "Los avances en el tratamiento de la diabetes tipo 1 han sido fundamentales para
More news about: Continuity Biosciences LLC
Mar 24, 2026, 10:28 ET Continuity Biosciences und Breakthrough T1D arbeiten zusammen, um die NICHE®-Zelltherapie-Plattform auf dem Weg zur First-in-Human-Studie voranzubringen
effektiv diese Therapien bereitgestellt, geschützt und über einen längeren Zeitraum aufrechterhalten werden können", sagte Ramakrishna Venugopalan, PhD, MBA, Mitbegründer und Chief Executive Officer von Continuity Biosciences. „Breakthrough T1D hat eine entscheidende Rolle dabei gespielt, den Fortschritt
More news about: Continuity Biosciences LLC
Mar 24, 2026, 10:17 ET CaringKind's Inaugural Dementia Education Conference Sells Out, Uniting the Full Spectrum of Voices in Dementia Care
Director of the Northwell Aging Institute; Sara Czaja, PhD, Professor of Gerontology in Medicine at Weill Cornell Medicine; Kendra Ray, PhD, MBA, MPH, MT-BC, LCAT, Chief Research Officer at CaringKind; and Mary Sano, PhD, Professor of Psychiatry at the Icahn School of Medicine at Mount
More news about: CaringKind
Mar 24, 2026, 09:37 ET Marine Biological Laboratory Receives $5 Million Gift from Valerie and John W. Rowe to Support Graduate Education
MBL/UChicago Graduate Research Fellowship Program brings together the strengths of the Marine Biological Laboratory and the existing University of Chicago PhD programs to provide graduate students with access to world-class research environments and collaborative scientific communities spanning all levels of
More news about: Marine Biological Laboratory
Mar 24, 2026, 09:30 ET First Parkinson's Patients Treated in Landmark Phase 2 Trial of Dapansutrile - Expanding a Leading Oral NLRP3 Inhibitor into Neurological Diseases
at Cambridge University Hospitals NHS Foundation Trust/University of Cambridge under principal investigator, Dr. Caroline Williams-Gray, BMBCh, FRCP, PhD, and funded by Cure Parkinson's and Van Andel Institute through the International Linked Clinical Trials program. This first 12-month duration study
More news about: Olatec Therapeutics, Inc.
Mar 24, 2026, 09:15 ET GS1 Connect 2026 Agenda Offers Supply Chain Innovation Best Practices Across Foodservice, Grocery, Healthcare and Retail Industries
Standards help drive efficiency, innovation and long–term growth."The conference includes a keynote address from bestselling author Natalie Nixon, PhD, who will explore how human creativity and emerging technologies intersect to help leaders and teams navigate change, adapt to uncertainty and build
More news about: GS1 US, Inc.
Mar 24, 2026, 09:14 ET Tampa General Hospital and USF Health Named Cancer Center of Excellence in Florida
five years, expanding access to all that we offer at the TGH Cancer Institute to reach more patients and save more lives," said Thomas Rutherford, MD, PhD, chief of the Division of Gynecological Oncology and professor in the Morsani College of Medicine as well as deputy director of the TGH Cancer Institute
More news about: Tampa General Hospital
Mar 24, 2026, 09:12 ET Tetrous® Strengthens Commercial Leadership with Appointment of Thurman Ballard as Vice President of Sales
products, building high-performing sales organizations, and leading teams to consistently deliver strong revenue growth. Tetrous' CEO, Dr. Bradley Patt, PhD said "We are thrilled to be able to attract someone with Thurman's extensive surgeon relationships and track record to our team. I am confident that
More news about: Tetrous
Mar 24, 2026, 09:03 ET Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia
700 unique growth factors and proteins and it has been clinically underutilized as a therapeutic source,2,3" said Trillitye Paullin, PhD, Chief Scientific Officer and cellular and molecular biologist with more than 15 years in the field. "By isolating and concentrating the extracellular
More news about: Xtressé™
Mar 24, 2026, 09:00 ET Worki Enables Healthcare System Partners to Remove Hundreds of Millions in Overhead with AI Workforce Unifying Infrastructure
structural problem. Founded Worki thesis to be the missing AI connective infrastructure layer.Harvey Hongwei Li, PhD - CTO - PhD in AI from UC Berkeley, tech lead of AI and machine learning at Uber and Airbnb. Recognized healthcare workforce challenges as the same pattern:
More news about: Worki
Mar 24, 2026, 09:00 ET Nursing Competency Framework Now Available as Default in iDesign's AI Curriculum Intelligence Platform
demonstrate competency alignment, and they shouldn't have to spend weeks configuring their tools before the real work begins," said Whitney Kilgore, PhD, Co-Founder and Chief Academic Officer of iDesign. "Making The Essentials available as a built-in default inside Align is about reducing friction so
More news about: idesignedu.org
Mar 24, 2026, 08:51 ET The Inner Circle acknowledges Dr. Romena Kiryakous, PsyD - Pioneering Behavioral Health and FirstPath Innovation
organizations.Dr. Kiryakous holds a Doctor of Psychology (PsyD) from the University of Arizona Global Campus, has completed all coursework (ABD) toward a PhD at the University of the Rockies, and also earned a Master of Arts in Psychology and a Bachelor of Arts in Sociology from California State University,
More news about: The Inner Circle
Mar 24, 2026, 08:30 ET Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development, Upcoming Webinar Hosted by Xtalks
OneSource Specialty Pharma, M.S. Vijaykanth PhD, SVP & Head – R&D; and Nandakumar Sundaramoorthy, PhD (Dr. rer. medic.), Director & Head – Analytical Development Department, for the live webinar on Wednesday, April 15,
More news about: Xtalks
Mar 24, 2026, 08:30 ET Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
David Spetzler, MS, PhD, MBA. "During Colorectal Cancer Awareness Month, it is important to recognize that DPYD testing can provide clinically meaningful information before
More news about: Caris Life Sciences
Mar 24, 2026, 08:24 ET Robert Hollingsworth has been appointed as the Chief Scientific Officer of Protillion Biosciences
March 24, 2026 /PRNewswire/ -- Protillion Biosciences today announced the appointment of Robert Hollingsworth, PhD, as Chief Scientific Officer. Dr. Hollingsworth is a seasoned drug development executive with a distinguished track record of advancing transformative
More news about: Protillion Biosciences, Inc.
Mar 24, 2026, 08:07 ET New Nutrition Research Links Fresh Pork to Muscle Health, Recovery, and Healthy Aging
"What these studies seem to show is that high-quality protein sources are foundational for muscle health across the lifespan," said Moul Dey, PhD, professor of nutrition science who leads functional nutrition research at South Dakota State University. "This research adds to the evidence that foods
More news about: National Pork Board
Mar 24, 2026, 08:00 ET Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
breakthrough cell therapies, but by how effectively those therapies can be delivered, protected, and sustained over time," said Ramakrishna Venugopalan, PhD, MBA, Co-Founder and Chief Executive Officer of Continuity Biosciences. "Breakthrough T1D has played a critical role in catalyzing progress across
More news about: Continuity Biosciences LLC
Mar 24, 2026, 08:00 ET Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
breakthrough cell therapies, but by how effectively those therapies can be delivered, protected, and sustained over time," said Ramakrishna Venugopalan, PhD, MBA, Co-Founder and Chief Executive Officer of Continuity Biosciences. "Breakthrough T1D has played a critical role in catalyzing progress across
More news about: Continuity Biosciences LLC
Mar 24, 2026, 08:00 ET Eduframe and LearnWise AI Support Scalable, Learner-Centered Continuing Education at the University of Chicago
Mary Morley Cohen, PhD, Managing Director of UChicago Professional. "Partnering with Eduframe and Learnwise AI allows us to remove friction behind the scenes so learners
More news about: Drieam LLC
Mar 24, 2026, 08:00 ET CodeSignal and Transform Launch Year-Round Skills Partnership to Turn 2026 Conference into Instant Hands-On Learning Courses
Skills: Practice aligning across the C-suite, leading AI enablement, and translating strategy into workforce execution.Dr. Amanda Welsh, PhD (Associate Dean, Workforce & Econ Dev, Northeastern University) + Jason Desentz (CHRO, Toshiba) + Taylor Stockton (Chief Innovation Officer, U.S.
More news about: CodeSignal
Mar 24, 2026, 08:00 ET Project InnerSpace and XPRIZE Announce Collaboration to Design Landmark Geothermal Surface Systems Prize
the right incentive, at the right moment, can unlock innovation that markets alone are too slow or too constrained to deliver," said David Babson, PhD, EVP of Energy, Climate, & Nature at XPRIZE. "In geothermal, the opportunity is increasingly about creating more deployable, efficient, and scalable
More news about: Project InnerSpace
Mar 24, 2026, 07:57 ET RYBODYN ANNOUNCES SEED FINANCING TO ADVANCE AI-DRIVEN DISCOVERY OF HIDDEN CANCER TARGETS
and we're now uncovering them at scale. RyboCypher™ and CypherAtlas™ provide a continuously expanding map of that hidden biology," said Imad Ajjawi, PhD, MBA, CEO and Co-founder of RyboDyn. "We're actively translating these discoveries into first-in-class therapies, both internally and with leading pharmaceutical
More news about: RyboDyn
Mar 24, 2026, 07:06 ET Biozen to Present Prospective Clinical Validation Data at ACC 2026
progress of our platform and the work behind it.""The study was designed to evaluate the device as it would be used in practice," said Omer Inan, PhD, Chief Scientific Officer of Biozen. "Prospective evaluation under the ISO validation framework is an important milestone for demonstrating the performance
More news about: Biozen, LLC
Mar 24, 2026, 07:00 ET Sweet Victory Gum Helps Type 1 Diabetics Halve Sweets Snacking in Pilot Clinical Trial
Led by Roy Eldor, PhD, the randomized, double-blind trial involved volunteers with type 1 diabetes mellitus (T1DM) who were struggling to keep their consumption of sweets
More news about: Sweet Victory
Mar 24, 2026, 07:00 ET Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
totality, these data underscore selinexor's potential to meaningfully improve clinical outcomes for patients with myelofibrosis," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research of Karyopharm. "On behalf of Karyopharm, I would like to thank the patients, families, caregivers, investigators,
More news about: Karyopharm Therapeutics Inc.